THE ASSOCIATION BETWEEN HBA1C LEVELS AND COGNITIVE FUNCTION IN GERIATRIC PATIENTS WITH TYPE 2 DIABETES MELLITUS

Irene Lingkan Parengkuan, Celine Elvirenov Oeylex, Ari Christy Muliono

Abstract


Background: Type 2 diabetes mellitus (T2DM) is a significant global health concern, particularly in Indonesia. Recent studies suggest a link between T2DM and increased risk of cognitive impairment. However, the relationship between glycaemic control, as measured by HbA1c levels, and cognitive function in elderly diabetic patients remains unclear and requires further investigation.

Objective: To investigate the association between HbA1c levels and cognitive impairment in geriatric patients with T2DM.

Methods: This observational analytic study with a cross-sectional approach was conducted at the Internal Medicine Clinic of Gotong Royong Hospital in Surabaya, Indonesia. Thirty-six geriatric T2DM patients were recruited using consecutive sampling. HbA1c levels were obtained from medical records, and cognitive function was assessed using the Montreal Cognitive Assessment-Indonesian Version (MoCA-INA). Data were analyzed using SPSS software, including normality tests and Spearman correlation analysis.

Results: The majority of participants were female (77.8%) and aged 60-69 years (47.2%). Eleven participants (50%) of the 22 T2DM geriatric patients with good-controlled HbA1c levels had poor cognitive function (scores < 26). Meanwhile, among the 14 participants with poorly controlled HbA1c levels, 11 (78.6%) had poor cognitive function, and only 3 (21.4%) maintained good cognitive function. A significant negative correlation was found between HbA1c levels and MoCA-INA scores (p=0.013, r=-0.410), indicating that higher HbA1c levels were associated with lower cognitive function scores.

Conclusion: This study demonstrates a significant relationship between HbA1c levels and cognitive function in elderly T2DM patients. Poor glycemic control is associated with a higher likelihood of cognitive impairment. These findings emphasize the importance of maintaining good glucose management to potentially prevent cognitive decline in this population. Further research with larger sample sizes and longitudinal designs is recommended to elucidate this relationship and its clinical implications.


Save to Mendeley


Keywords


Type 2 Diabetes Mellitus; Geriatric; HbA1C; Cognitive function

Full Text:

PDF

References


IDF Diabetes Atlas. 10th ed. Vol. 102, Diabetes Research and Clinical Practice. 2021.

Wang M, Hng TM. HbA1c: More than just a number. Aust J Gen Pract. 2021 Sep;50(9):628-632. doi: 10.31128/AJGP-03-21-5866. PMID: 34462769.

American Diabetes Association. 2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes-2021. Diabetes Care. 2021 Jan;44(Suppl 1):S15-S33. doi: 10.2337/dc21-S002. Erratum in: Diabetes Care. 2021 Sep;44(9):2182. doi: 10.2337/dc21-ad09. PMID: 33298413.

Damanik J, Yunir E. Type 2 Diabetes Mellitus and Cognitive Impairment. 2021;53(2). Available from: http://www.actamedindones.org/index.php/ijim/article/view/979/pdf

Sun L, Diao X, Gang X, Lv Y, Zhao X, Yang S, et al. Risk Factors for Cognitive Impairment in Patients with Type 2 Diabetes. J Diabetes Res [Internet]. 2020 [cited 2023 Apr 20];2020. Available from: /pmc/articles/PMC7196145/

Malik A, Ahmed M, Mansoor S, Ambreen S, Usman B, Shehryar M. Cognitive Impairment in Type 2 Diabetes Mellitus. Cureus [Internet]. 2022 Feb 14 [cited 2023 Mar 31];14(2):59. Available from: /pmc/articles/PMC8925983/

Marden JR, Mayeda ER, Tchetgen EJ, Kawachi I, Glymour MM. High Hemoglobin A1c and Diabetes Predict Memory Decline in the Health and Retirement Study. Alzheimer Dis Assoc Disord [Internet]. 2018 [cited 2023 Apr 5];31(1). Available from: /pmc/articles/PMC5325158/

Song R, Fan X, Seo J. Physical and cognitive function to explain the quality of life among older adults with cognitive impairment: exploring cognitive function as a mediator. BMC Psychol. 2023 Feb 22;11(1):51. doi: 10.1186/s40359-023-01087-5. Erratum in: BMC Psychol. 2023 Mar 7;11(1):63. doi: 10.1186/s40359-023-01108-3. PMID: 36814329; PMCID: PMC9948328.

Zhang Q, Wu Y, Han T, Liu E. Changes in Cognitive Function and Risk Factors for Cognitive Impairment of the Elderly in China: 2005–2014. Int J Environ Res Public Health [Internet]. 2019 Aug 2 [cited 2023 Apr 19];16(16). Available from: /pmc/articles/PMC6719934/

Kelso IG, Tadi P. Cognitive Assessment. StatPearls [Internet]. 2022 Nov 7 [cited 2023 Apr 19]; Available from: https://www.ncbi.nlm.nih.gov/books/NBK556049/

Rambe AS, Fitri FI. Correlation between the Montreal Cognitive Assessment-Indonesian Version (Moca-INA) and the Mini-Mental State Examination (MMSE) in Elderly. Open Access Maced J Med Sci [Internet]. 2017 Dec 12 [cited 2023 Mar 31];5(7):915. Available from: /pmc/articles/PMC5771294/

Dyer AH, Briggs R, Laird E, Hoey L, Hughes CF, McNulty H, et al. Glycated haemoglobin (HbA1c), diabetes and neuropsychological performance in community-dwelling older adults. Diabet Med. 2021;38(11)

Kim HG. Cognitive dysfunctions in individuals with diabetes mellitus. Yeungnam Univ J Med [Internet]. 2019 Sep 30 [cited 2023 Apr 20];36(3):183. Available from: /pmc/articles/PMC6784656/

Aderinto N, Olatunji G, Abdulbasit M, Ashinze P, Faturoti O, Ajagbe A, Ukoaka B, Aboderin G. The impact of diabetes in cognitive impairment: A review of current evidence and prospects for future investigations. Medicine (Baltimore). 2023 Oct 27;102(43):e35557. doi: 10.1097/MD.0000000000035557. PMID: 37904406; PMCID: PMC10615478.

Ware EB, Morataya C, Fu M, Bakulski KM. Type 2 Diabetes and Cognitive Status in the Health and Retirement Study: A Mendelian Randomization Approach. Front Genet. 2021 Mar 25;12:634767. doi: 10.3389/fgene.2021.634767. PMID: 33868373; PMCID: PMC8044888.

Sebastian MJ, Khan SK, Pappachan JM, Jeeyavudeen MS. Diabetes and cognitive function: An evidence-based current perspective. World J Diabetes. 2023 Feb 15;14(2):92-109. doi: 10.4239/wjd.v14.i2.92. PMID: 36926658; PMCID: PMC10011899.

Sharma G, Parihar A, Talaiya T, Dubey K, Porwal B, Parihar MS. Cognitive impairments in type 2 diabetes, risk factors and preventive strategies. J Basic Clin Physiol Pharmacol [Internet]. 2020 Mar 1 [cited 2023 Apr 28];31(2). Available from: https://www.degruyter.com/document/doi/10.1515/jbcpp-2019-0105/html

Gupta M, Pandey S, Rumman M, Singh B, Mahdi AA. Molecular mechanisms underlying hyperglycemia associated cognitive decline. IBRO Neurosci Reports [Internet]. 2023 Jun 1 [cited 2023 Apr 30];14:57. Available from: /pmc/articles/PMC9800261/

Pignalosa FC, Desiderio A, Mirra P, Nigro C, Perruolo G, Ulianich L, et al. Diabetes and Cognitive Impairment: A Role for Glucotoxicity and Dopaminergic Dysfunction. Int J Mol Sci [Internet]. 2021 Nov 1 [cited 2023 Apr 29];22(22). Available from: /pmc/articles/PMC8619146/

Yerrapragada DB, Rao CR, Karunakaran K, Lee HSE. Cognitive Dysfunction Among Adults With Type 2 Diabetes Mellitus in Karnataka, India. Ochsner J [Internet]. 2019 Sep 1 [cited 2023 Apr 30];19(3):227. Available from: /pmc/articles/PMC6735609/




DOI: https://doi.org/10.33508/jwmj.v6i4.6016

Refbacks

  • There are currently no refbacks.